Abstract:OBJECTIVE:To provide the theoretical supportting for targeted heparanase (HPA) inhibition of cervical cancer through observing the anti-proliferative effect of the HPA inhibitor on HeLa cell line of cervical cancer.METHODS:The two series of 13 kinds of novel HPA inhibitors were synthesized and optimized. Heparan degrading enzyme assay kit was used to test the effect of the inhibitors on the inhibition of HPA enzyme activity. Methyl thiazolyl tetrazolium (MTT) method and scratch test were used to observe the anti-proliferative and the migration effect of the inhibitors on HeLa cells. Flow cytometry was performed to determine the cell cycles and apoptosis. The expression of HPA was evaluated by reverse transcription (RT)-PCR, western blot and immunocytochemistry.RESULTS:All tested inhibitors could inhibit the activity of HPA enzyme [the range of 50% inhibiting concentration (IC50) values from 4.47 to 47.19 µmol/L] and the growth of HeLa cells (the range of IC50 values from 48.16 to 96.64 µmol/L). Among them, No.16 compound exhibits the strongest inhibition against the growth of HeLa, which could arrest the cell into G0/G1 and G2/M phases. The rate of cell apoptosis in the group treated with 50 µmol/L No.16 for 48 hours [(11.9 ± 1.2)%] was significantly higher than that [(6.6 ± 1.8)%] in untreated group (P = 0.013). Real time PCR and western blot showed that expression levels of HPA mRNA (1.23 ± 0.46) and protein (0.46 ± 0.31) significantly decreased in the treated group as compared with the levels of HPA mRNA (3.43 ± 0.45) and protein (1.30 ± 0.58) in the untreated group (both P < 0.05). Immunocytochemistry also showed that the treatment of No.16 significantly reduced the average optical density (0.39 ± 0.04) of HPA immuostaining signal compared with that in the control group (0.50 ± 0.09; P = 0.026).CONCLUSION:Novel 1,3-O,N spiroheterocyclic HPA inhibitors could inhibit the proliferation of HeLa cells, inhibit the HPA enzyme activity in different degree, and downregulate the expression of HPA protein.

Effect of Heparanase Antisense Oligodeoxynucleotide on Adhesion, Invasion and Apoptosis of Lung Cancer A549 Cells

Inhibition of invasiveness of human lung cancer cell lines by heparanase antisense oligodeoxynucleotide

Inhibitory Effects of Heparanase Antisense Oligodeoxynucleotide on Human Lung Cancer Cells Transplanted Subcutaneously in Nude Mice

Effects of Heparanase Inhibition by RNA Interference on Proliferation,invasiveness and Apoptosis of Lung Cancer Cells

Lentiviral Mir30-Based Rna Interference Against Heparanase Suppresses Melanoma Metastasis With Lower Liver And Lung Toxicity

Down-Regulation of Heparanase Leads to the Inhibition of Invasion and Proliferation of A549 Cells in Vitro and in Vivo

Effect of heparanase on the adhesion and invasion ability of hepa-toma carcinoma cells

An Artificial Mirna Against Hpse Suppresses Melanoma Invasion Properties, Correlating With A Down-Regulation Of Chemokines And Mapk Phosphorylation

EFFECTS OF DIFFERENT CONCENTRATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDES(ASODN) ON HUMAN PANCREATIC CANCER CELL LINE PaTu8988s

[Inhibitory Effect of Silencing Heparanase Expression with Antisense Oligodeoxynucleotide on Invasive Capability of Human Esophageal Squamous Cancer Cell Line TE-13].

Inhibitory Effect of Heparanase Antisense Oligodeoxynucleotides on Invasiveness Ofbel-7402 Cell Line

Transfection of Antisense Oligodeoxynucleotide Inhibits Heparanase Gene Expression and Invasive Ability of Human Pancreatic Cancer Cell in Vitro.

Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells

Effect of Sense and Antisense Human Heparanase Gene on Metastatic Potential of Hepatocarcinoma Cells

Influence of MMP-9 antiseme oligonudeotide on proliferation and apoptosis of human lung adenocarcinom A549 cells

Effects of Targeted Heparanase Sirna on Malignant Biological Behaviors of Human Colon Carcinoma Cells

[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell].

Construction of heparanase gene-targeted small interfering RNA and its gene silencing effect]

[Effect of 1,3-O,N Spiroheterocyclic Inhibitors of Heparanase on the Growth of HeLa Cells].

The expression of heparanase and microRNA-1258 in human non-small cell lung cancer

[Effect on Invasion Ability of Cervical Cancer Cells after Silence Heparanase Gene Expression in Hela Cells].